CD33 and proximal spinal muscular atrophy: As mentioned in the section on “Spot analysis of SMN protein in CD33++ cells” the SD of all evaluations of the SMA subjects was lesser than that of the control subjects (SMA SD < control SD) (online Supporting S6 Table).